首页> 外文期刊>Chemical biology and drug design >Design, Synthesis and Biological Evaluation of Two Opioid Agonist and Ca(v)2.2 Blocker Multitarget Ligands
【24h】

Design, Synthesis and Biological Evaluation of Two Opioid Agonist and Ca(v)2.2 Blocker Multitarget Ligands

机译:两种阿片类激动剂和Ca(v)2.2阻滞剂多靶标配体的设计,合成和生物学评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

N-type voltage-dependent Ca2+ channels (Ca(V)2.2) are located at nerve endings in the central and peripheral nervous systems and are strongly associated with the pathological processes of cerebral ischaemia and neuropathic pain. Ca(V)2.2 blockers such as the omega-conotoxin MVIIA (Prialt) are analgesic and have opioid-sparing effects. With the aim to develop new multitarget analgesic compounds, we designed the first omega-conotoxin/opioid peptidomimetics based on the enkephalin-like sequence Tyr-D-Ala-Gly-Phe (for the opioid portion) and two fragments derived from the loop-2 pharmacophore of omega-conotoxin MVIIA. Antinociceptive activity evaluated in vitro and in vivo revealed differential affinity for Ca(V)2.2 and opioid receptors and no significant synergistic activity.
机译:N型电压依赖性Ca2 +通道(Ca(V)2.2)位于中枢神经系统和末梢神经系统的神经末梢,与脑缺血和神经性疼痛的病理过程密切相关。 Ca(V)2.2阻滞剂,例如ω-芋螺毒素MVIIA(普利特)具有镇痛作用,具有阿片类药物的保护作用。为了开发新的多靶点镇痛药,我们基于脑啡肽样序列Tyr-D-Ala-Gly-Phe(针对阿片类药物)设计了首个欧米茄-芋螺毒素/类阿片肽模拟物,并从环上衍生了两个片段2ω-芋螺毒素MVIIA的药效团。在体外和体内评估的抗伤害感受活性表明对Ca(V)2.2和阿片样物质受体具有不同的亲和力,并且没有明显的协同活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号